イスラエルで最高のMRガイド下集束超音波治療医師 - トップ7名の医師

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Achinoam Socher is a Neurologist And Movement Disorder Specialist at Tel Aviv Sourasky Medical Center, providing key insights in Neurology and the Medical & Health Department. Here are the key takeaways about him:

• Works at Tel Aviv Sourasky Medical Center
• Part of the Neurology team
• Based in Tel Aviv, Israel
• Part of a Hospitals & Physicians Clinics company founded in 1985

イツハク・フリード教授は、世界で最も優れた脳神経外科医であり、神経科学者の一人です。

フリード博士はスタンフォード大学を卒業し、イェール大学（いずれもアメリカ合衆国）でのトレーニングを経ました。

イツハク・フリード教授の専門分野は以下の通りです：

• 子どもと大人に対する高度な脳手術
• てんかんの治療（外科手術を含む）および研究
• 脳深部刺激療法
• 機能的脳マッピング
• てんかんに関連する血管奇形の治療。

フリード教授の科学的発見：

• てんかん発作の性質と発展を研究する革新的アプローチ
• てんかんに起因する言語および記憶障害の回復のための新しい方法
• てんかん患者の管理に関する最新プログラムおよび治療ガイドの策定。

現在、教授はイヒロフ病院（イスラエル）で患者を受け入れ、UCLAのデイヴィッド・ゲフィン・スクール・オブ・メディシンやイェール大学（いずれもアメリカ合衆国）、テルアビブ医療センター（イスラエル）で教鞭をとっています。

Prof. Roy Mashiach, MD, is the Director of Gynecology at Sheba Medical Center. He is a leading expert in minimally invasive gynecologic surgery with over 30 years of experience. He focuses on laparoscopic and hysteroscopic hysterectomy. He also performs myoma removal, treats endometriosis, and offers fertility‑preserving procedures.

Recognition and roles: Named to Forbes Israel’s Best Doctors. Recipient of the Daniel F. Kott Award (AAGL). Chairman of the Israeli Society of Gynecological Endoscopy. Director of the Gynecologic Simulation Unit (M.S.R.). Clinical Associate Professor at Tel Aviv University. Training: MD from Tel Aviv University. Specialization at Lis Maternity & Women’s Hospital. Fellowship in Advanced Endoscopy at Université d’Auvergne.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Eduard Linecki is a leading neurologist at the Hadassah Medical Center, with over 23 years of experience, specializing in neurology, polyneuropathy, neurooncology, and Parkinson's disease.

• Specializes in the treatment of all types of disorders of the nervous system
• Achieved success in the treatment of Parkinson's disease
• Completed an internship at Hadassah Medical Center in 2001
• Received a higher medical education in 1996

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.